2[1]Boumpas DT, Austin III HA, Vaughan EM, et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med, 1993; 119(5):366
3[2]Blow JE, Boumpas DT, Fessler BJ, et al. Management of lupus nephritis. Kidney International, 1996; 49(Suppl 53):88
4[3]Out HJ, Groot PGD, Hasselaar P, et al. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. AnnRheum Dis, 1989; 48(12):1023
5[4]Chapman RM, Sutcliffe SB. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood, 1981; 58(4):849
6[5]Montz FJ, Wolff AJ, Gambone JC. Gonadal protection and fecundity rates in cyclophosphamide-treated rats. Cancer Research, 1991; 51(8):2124
7[6]Gourley MF, Austin Ⅲ HA, Scott D, et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. Ann Intern Med, 1996; 125(7):549
8[7]Mills JA.Systemic lupus erythematosus. N Engl J Med, 1994;330(26):1871
9Milena MV,Francisco YB,Macêdo,et al.Ternatin,a flavonoid,prevents cyclophosphamide and ifosfamideinduced hemorrhagic cystitis in rats[J].Phytother Res,2004,18(2):135-141.
10Wolf-Dietrich B,Tobias E,Roman B,et al.Angiogenesis inhibition by angiostatin,endostatin and TNP-470 prevents cyclophosphamide induced cystitis[J].Angiogenesis,2004,7(1):69-73.
